HIV Testing, Prevention and Care Interventions, 2nd Edition

Dear Colleagues,

Human immunodeficiency virus (HIV) infection is a growing problem all around the world that, if not diagnosed and treated early, might cause acquired immunodeficiency syndrome (AIDS), the most advanced stage of HIV infection. The worldwide strategy promoted by the World Health Organization (WHO) and the United Nations UNAIDS aims for 95% of people living with HIV to know their status, 95% of people diagnosed with HIV to be on antiretroviral therapy (ART), and 95% of people on ART to achieve viral suppression. It is well known that the risk factors for HIV include having vaginal or anal sex with someone who is HIV-positive or whose HIV status is unknown; having sex with many partners; and injecting drugs and sharing needles, syringes, or other drug equipment with others. For example, the Centers for Disease Control and Prevention (CDC) in the US recommends that everyone 13 to 64 years of age get tested for HIV at least once as part of routine healthcare and that people at higher risk for HIV get tested more often. The healthcare provider of those over 64 years of age and at risk of HIV may recommend HIV testing. Also, the CDC recommends that all pregnant women get tested for HIV so that they can begin taking HIV medicines if they are HIV-positive. In addition, to achieve viral suppression, it is crucial that laboratory monitoring of this parameter is performed in the person living with HIV. However, full access to testing is not possible everywhere; this is not only due to a lack of resources but also as a result of legal, cultural, and religious barriers, plus the stigma associated with HIV. For those reasons, this Special Issue is primarily focused on sharing experiences and pitfalls in individuals’ realities with the aim of overcoming HIV testing barriers and developing strategies to set proper prevention and care interventions.

In addition, this Special Issue intends to be enriched with quantitative data, rather than descriptive studies, to provide additional tools for decision-makers focused on the important public health aspects concerning people with HIV, particularly to ensure that HIV is completely under control and improve the awareness of the HIV-negative population.

Dr. Ricardo Izurieta
Prof. Dr. Enrique Terán
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Tropical Medicine and Infectious Disease is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• HIV testing
• HIV stigma
• HIV prevention
• HIV care

• HIV Testing, Prevention and Care Interventions in Tropical Medicine and Infectious Disease (7 articles)